Review



γh 2 ax primary antibody  (Bethyl)


Bioz Verified Symbol Bethyl is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    Bethyl γh 2 ax primary antibody
    γh 2 Ax Primary Antibody, supplied by Bethyl, used in various techniques. Bioz Stars score: 91/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/%CE%B3h+2+ax+primary+antibody/COX-2+Antibody/pmc05870477-44-12-20
    Average 91 stars, based on 11 article reviews
    γh 2 ax primary antibody - by Bioz Stars, 2026-09
    91/100 stars

    Images

    Related Articles

    Produced:

    Article Title: Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2
    Article Snippet: D5D primary antibody (from rabbit) and β-actin primary antibody (from mouse) were purchased from Sigma-Aldrich (MO, USA). .. COX-2 primary antibody produced in rabbit was purchased from Abcam (MA, USA). γH 2 AX primary antibody was purchase from Bethyl Laboratories (TX, USA). ..

    Article Title: Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism
    Article Snippet: HDAC activity assay kit was purchased from BioVision (CA, USA). .. COX-2 primary antibody produced in rabbit was acquired from Abcam (MA, USA). γH 2 AX primary antibody was purchased from Bethyl Laboratories (TX, USA). ..



    Similar Products

    primary antibodies against γh 2 ax  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc primary antibodies against γh 2 ax
    a Protein levels of NOX4, NQO1, SOD2, and GPX4 in A549 and H1299 cells after various concentrations of apatinib treatment. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group. b Protein levels of NOX4, NQO1, SOD2, and GPX4 in apatinib (5 μM)-treated cells treated with/without 5 mM NAC or 200 μM H 2 O 2 for 48 h. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; # p < 0.05, ## p < 0.01 compared to the apatinib (5 μM) group. c Immunofluorescence analysis of JC-1 in cells after various concentrations of apatinib treatment for 24 h. Scale bar = 25 μm. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). ** p < 0.01 compared to the control group. d Immunofluorescence analysis of <t>γH</t> <t>2</t> AX (red) in apatinib (1 μM) -treated cells with/without 5 mM NAC or 200 μM H 2 O 2 . DAPI: blue. Scale bar = 100 μm. e Sphere formation assays of apatinib (1 μM)-treated with/without 5 mM NAC or 200 μM H 2 O 2 . Scale bar = 100 μm. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; # p < 0.05, ## p < 0.01 compared to the apatinib (1 μM) group. f Protein levels of ALDH1A1 and ABCG2 in apatinib (5 μM) treated with/without 5 mM NAC or 200 μM H 2 O 2 48 h. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; ## p < 0.01 compared with the apatinib (5 μM) group. g Schematic representation of the effects of apatinib on lung CSC-like properties by inducing redox imbalance.
    Primary Antibodies Against γh 2 Ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/%CE%B3h+2+ax+primary+antibody/ABCG2+Antibody/pmc08115647-353-42-47
    Average 90 stars, based on 1 article reviews
    primary antibodies against γh 2 ax - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    γh 2 ax primary antibody  (Bethyl)
    91
    Bethyl γh 2 ax primary antibody
    a Protein levels of NOX4, NQO1, SOD2, and GPX4 in A549 and H1299 cells after various concentrations of apatinib treatment. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group. b Protein levels of NOX4, NQO1, SOD2, and GPX4 in apatinib (5 μM)-treated cells treated with/without 5 mM NAC or 200 μM H 2 O 2 for 48 h. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; # p < 0.05, ## p < 0.01 compared to the apatinib (5 μM) group. c Immunofluorescence analysis of JC-1 in cells after various concentrations of apatinib treatment for 24 h. Scale bar = 25 μm. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). ** p < 0.01 compared to the control group. d Immunofluorescence analysis of <t>γH</t> <t>2</t> AX (red) in apatinib (1 μM) -treated cells with/without 5 mM NAC or 200 μM H 2 O 2 . DAPI: blue. Scale bar = 100 μm. e Sphere formation assays of apatinib (1 μM)-treated with/without 5 mM NAC or 200 μM H 2 O 2 . Scale bar = 100 μm. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; # p < 0.05, ## p < 0.01 compared to the apatinib (1 μM) group. f Protein levels of ALDH1A1 and ABCG2 in apatinib (5 μM) treated with/without 5 mM NAC or 200 μM H 2 O 2 48 h. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; ## p < 0.01 compared with the apatinib (5 μM) group. g Schematic representation of the effects of apatinib on lung CSC-like properties by inducing redox imbalance.
    γh 2 Ax Primary Antibody, supplied by Bethyl, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/%CE%B3h+2+ax+primary+antibody/COX-2+Antibody/pmc05870477-44-12-20
    Average 91 stars, based on 1 article reviews
    γh 2 ax primary antibody - by Bioz Stars, 2026-09
    91/100 stars
    		  Buy from Supplier

    Image Search Results


    a Protein levels of NOX4, NQO1, SOD2, and GPX4 in A549 and H1299 cells after various concentrations of apatinib treatment. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group. b Protein levels of NOX4, NQO1, SOD2, and GPX4 in apatinib (5 μM)-treated cells treated with/without 5 mM NAC or 200 μM H 2 O 2 for 48 h. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; # p < 0.05, ## p < 0.01 compared to the apatinib (5 μM) group. c Immunofluorescence analysis of JC-1 in cells after various concentrations of apatinib treatment for 24 h. Scale bar = 25 μm. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). ** p < 0.01 compared to the control group. d Immunofluorescence analysis of γH 2 AX (red) in apatinib (1 μM) -treated cells with/without 5 mM NAC or 200 μM H 2 O 2 . DAPI: blue. Scale bar = 100 μm. e Sphere formation assays of apatinib (1 μM)-treated with/without 5 mM NAC or 200 μM H 2 O 2 . Scale bar = 100 μm. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; # p < 0.05, ## p < 0.01 compared to the apatinib (1 μM) group. f Protein levels of ALDH1A1 and ABCG2 in apatinib (5 μM) treated with/without 5 mM NAC or 200 μM H 2 O 2 48 h. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; ## p < 0.01 compared with the apatinib (5 μM) group. g Schematic representation of the effects of apatinib on lung CSC-like properties by inducing redox imbalance.

    Journal: Cell Death Discovery

    Article Title: Apatinib suppresses lung cancer stem-like cells by complex interplay between β-catenin signaling and mitochondrial ROS accumulation

    doi: 10.1038/s41420-021-00480-6

    Figure Lengend Snippet: a Protein levels of NOX4, NQO1, SOD2, and GPX4 in A549 and H1299 cells after various concentrations of apatinib treatment. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group. b Protein levels of NOX4, NQO1, SOD2, and GPX4 in apatinib (5 μM)-treated cells treated with/without 5 mM NAC or 200 μM H 2 O 2 for 48 h. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; # p < 0.05, ## p < 0.01 compared to the apatinib (5 μM) group. c Immunofluorescence analysis of JC-1 in cells after various concentrations of apatinib treatment for 24 h. Scale bar = 25 μm. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). ** p < 0.01 compared to the control group. d Immunofluorescence analysis of γH 2 AX (red) in apatinib (1 μM) -treated cells with/without 5 mM NAC or 200 μM H 2 O 2 . DAPI: blue. Scale bar = 100 μm. e Sphere formation assays of apatinib (1 μM)-treated with/without 5 mM NAC or 200 μM H 2 O 2 . Scale bar = 100 μm. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; # p < 0.05, ## p < 0.01 compared to the apatinib (1 μM) group. f Protein levels of ALDH1A1 and ABCG2 in apatinib (5 μM) treated with/without 5 mM NAC or 200 μM H 2 O 2 48 h. One-way ANOVA (Bonferroni’s multiple-comparison test) was used. Data are presented as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01 compared to the control group; ## p < 0.01 compared with the apatinib (5 μM) group. g Schematic representation of the effects of apatinib on lung CSC-like properties by inducing redox imbalance.

    Article Snippet: The cells or spheroids were fixed, permeabilized, incubated with 5% bovine serum albumin for 1 h, and then incubated with primary antibodies against CD133 (1:100 dilution, Proteintech), CD44 (1:200 dilution, Proteintech), β-catenin (1:200 dilution, Proteintech), ABCG2 (1:100 dilution, Cell Signaling Technology) and γH 2 AX (1:200 dilution, Cell Signaling Technology) overnight at 4 °C.

    Techniques: Immunofluorescence